基于 1 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Discover the full record of transactions filed by Ball Jack, 董事. Director active across 1 company, notably Cytek Biosciences, Inc.. Cumulatively, 5 reports have been recorded. Split: 1 buy · 0 sell. Total volume traded: €43k. History available since 22 July 2021. The latest transaction was disclosed on 29 November 2022 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Ball Jack is a Board Member at Cytek Biosciences, Inc. He contributes to the governance and strategy of the company, bringing his expertise in the life sciences field. His role is crucial in guiding decisions that affect the future of Cytek Biosciences.